Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system
- PMID: 21108024
- DOI: 10.1007/s11906-010-0171-x
Endothelial damage and regeneration: the role of the renin-angiotensin-aldosterone system
Abstract
The renin-angiotensin-aldosterone system (RAAS) is part of the blood pressure regulating system. Its main effector peptide is angiotensin II (Ang II). Although it may induce hypertension, the proinflammatory, profibrotic, and prothrombotic effects are mainly mediated by effects of Ang II on the cellular and molecular level that are independent of blood pressure. Therefore, pharmacotherapeutic intervention within the RAAS is an important treatment modality for patients suffering from cardiovascular diseases, even those who are not hypertensive. In addition to the blood pressure lowering and vasculoprotective (pleiotropic) effects of angiotensin II type 1 (AT(1)) receptor blockers (ARBs), and angiotensin-converting enzyme (ACE) inhibitors, regenerative progenitor cell therapy emerges as an auxiliary therapy to improve regeneration of the vascular endothelium. This review focuses on the growing knowledge about regenerating vascular cells, their response to RAAS effectors, and RAAS-modulating pharmacotherapy in the context of endothelial cell damage and regeneration.
Similar articles
-
Hypertension: renin-angiotensin-aldosterone system alterations.Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587. Circ Res. 2015. PMID: 25767283 Review.
-
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?Expert Opin Pharmacother. 2007 Apr;8(5):529-35. doi: 10.1517/14656566.8.5.529. Expert Opin Pharmacother. 2007. PMID: 17376010 Review.
-
Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.Future Cardiol. 2009 Sep;5(5):453-65. doi: 10.2217/fca.09.31. Future Cardiol. 2009. PMID: 19715410 Review.
-
Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.Nat Rev Cardiol. 2013 Apr;10(4):183-4. doi: 10.1038/nrcardio.2013.28. Epub 2013 Mar 12. Nat Rev Cardiol. 2013. PMID: 23478259
-
[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].Harefuah. 2008 Jun;147(6):536-42, 573. Harefuah. 2008. PMID: 18693632 Review. Hebrew.
Cited by
-
Effects of Tiaozhi Granule on Regulation of Autophagy Levels in HUVECs.Evid Based Complement Alternat Med. 2018 Jul 12;2018:1765731. doi: 10.1155/2018/1765731. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30108646 Free PMC article.
-
Angiotensin II-Induced Apoptosis of Human Umbilical Vein Endothelial Cells was Inhibited by Blueberry Anthocyanin Through Bax- and Caspase 3-Dependent Pathways.Med Sci Monit. 2016 Sep 12;22:3223-8. doi: 10.12659/msm.896916. Med Sci Monit. 2016. PMID: 27616275 Free PMC article.
-
Intersectin-1s: an important regulator of cellular and molecular pathways in lung injury.Pulm Circ. 2013 Sep;3(3):478-98. doi: 10.1086/674439. Epub 2013 Dec 5. Pulm Circ. 2013. PMID: 24618535 Free PMC article.
-
ß-2 microglobulin level is negatively associated with global left ventricular longitudinal peak systolic strain and left atrial volume index in patients with chronic kidney disease not on dialysis.Anatol J Cardiol. 2016 Nov;16(11):844-849. doi: 10.14744/AnatolJCardiol.2015.6691. Epub 2016 Mar 23. Anatol J Cardiol. 2016. PMID: 27025200 Free PMC article.
-
Vitamin D Deficiency Is a Potential Risk for Blood Pressure Elevation and the Development of Hypertension.Medicina (Kaunas). 2021 Nov 25;57(12):1297. doi: 10.3390/medicina57121297. Medicina (Kaunas). 2021. PMID: 34946242 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous